Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-04

Clinical Trial Update: PF-06372865 In Subjects With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of PF-06372865 in chronic low back pain has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-06372865

Snippet

Sponsor: Pfizer | Conditions: Chronic Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2017-01-04